These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19875545)

  • 1. Viewpoints on the way to a consensus session: where does insulin resistance start? The liver.
    Perseghin G
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S164-7. PubMed ID: 19875545
    [No Abstract]   [Full Text] [Related]  

  • 2. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.
    Iozzo P
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S168-73. PubMed ID: 19875546
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.
    Michael MD; Kulkarni RN; Postic C; Previs SF; Shulman GI; Magnuson MA; Kahn CR
    Mol Cell; 2000 Jul; 6(1):87-97. PubMed ID: 10949030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes: the importance of the liver.
    Rutter GA
    Curr Biol; 2000 Oct; 10(20):R736-8. PubMed ID: 11069096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform.
    Escribano O; Guillén C; Nevado C; Gómez-Hernández A; Kahn CR; Benito M
    Diabetes; 2009 Apr; 58(4):820-8. PubMed ID: 19136656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver adapts mitochondrial function to insulin resistant and diabetic states in mice.
    Franko A; von Kleist-Retzow JC; Neschen S; Wu M; Schommers P; Böse M; Kunze A; Hartmann U; Sanchez-Lasheras C; Stoehr O; Huntgeburth M; Brodesser S; Irmler M; Beckers J; de Angelis MH; Paulsson M; Schubert M; Wiesner RJ
    J Hepatol; 2014 Apr; 60(4):816-23. PubMed ID: 24291365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway.
    Xu M; Ge C; Zhu L; Qin Y; Du C; Lou D; Li Q; Hu L; Sun Y; Dai X; Xiong M; Long T; Zhan J; Kuang Q; Li H; Yang Q; Huang P; Teng X; Feng J; Wu Y; Dong W; Wang B; Tan J
    Hepatology; 2021 Apr; 73(4):1346-1364. PubMed ID: 32592194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
    Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
    J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
    Tilg H; Moschen AR
    Trends Endocrinol Metab; 2008 Dec; 19(10):371-9. PubMed ID: 18929493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis.
    Baumgartl J; Baudler S; Scherner M; Babaev V; Makowski L; Suttles J; McDuffie M; Tobe K; Kadowaki T; Fazio S; Kahn CR; Hotamisligil GS; Krone W; Linton M; Brüning JC
    Cell Metab; 2006 Apr; 3(4):247-56. PubMed ID: 16581002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
    Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
    Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and steatosis in humans.
    Capeau J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and Insulin Resistance: Biochemical and Molecular Aspects.
    Cruz KJC; de Oliveira ARS; Morais JBS; Severo JS; Mendes PMV; de Sousa Melo SR; de Sousa GS; Marreiro DDN
    Biol Trace Elem Res; 2018 Dec; 186(2):407-412. PubMed ID: 29564656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and insulin resistance.
    Machado M; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2005 Aug; 17(8):823-6. PubMed ID: 16003131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty liver and insulin resistance: not always linked.
    Schonfeld G; Yue P; Lin X; Chen Z
    Trans Am Clin Climatol Assoc; 2008; 119():217-23; discussion 223-4. PubMed ID: 18596860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.
    Brüning JC; Michael MD; Winnay JN; Hayashi T; Hörsch D; Accili D; Goodyear LJ; Kahn CR
    Mol Cell; 1998 Nov; 2(5):559-69. PubMed ID: 9844629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
    Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into insulin resistance and type 2 diabetes from knockout mouse models.
    Kadowaki T
    J Clin Invest; 2000 Aug; 106(4):459-65. PubMed ID: 10953020
    [No Abstract]   [Full Text] [Related]  

  • 20. From mice to men: insights into the insulin resistance syndromes.
    Biddinger SB; Kahn CR
    Annu Rev Physiol; 2006; 68():123-58. PubMed ID: 16460269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.